Especially, the newest medical treatment options, such like gonadotropin-releasing hormone (GnRH) analogs, GnRH antagonists and selective progesterone receptor modulators, for symptomatic Uterine fibroids are now developed for women with uterine fibroids [4, 5]. The gene discussed is GNRH1; the disease is uterine corpus leiomyoma.